Grifols (GRFS) Inventory (2009 - 2025)
Grifols (GRFS) posted Inventory of $3.8 billion for Q4 2025, up 0.85% quarter-over-quarter from $3.8 billion in Q4 2024, and up 0.85% year-on-year from $3.8 billion in Q4 2024.
Grifols (GRFS) Inventory (2009 - 2025) Analysis & Trends
Grifols (GRFS) has reported Inventory for 16 consecutive years, with $3.8 billion the latest figure, recorded in Q4 2025.
- Inventory for Q4 2025 came in at $3.8 billion, up 0.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 billion (up 0.85% YoY), and the FY2025 annual result was $3.8 billion, up 0.85% from the prior year.
- Inventory was $3.8 billion for Q4 2025 at Grifols, up from $3.8 billion in the prior quarter.
- Over five years, Inventory peaked at $3.8 billion in Q4 2025 and troughed at -$181.6 million in Q4 2021.
- Average Inventory over 5 years is $1.4 billion, with a median of -$86.7 million recorded in 2022.
- Year-over-year, Inventory sank 53.85% in 2023 and jumped 2951.37% in 2024.
- Over 5 years, Inventory stood at -$181.6 million in 2021, then jumped by 52.24% to -$86.7 million in 2022, then tumbled by 53.85% to -$133.4 million in 2023, then jumped by 2951.37% to $3.8 billion in 2024, then grew by 0.85% to $3.8 billion in 2025.
- Per Business Quant data, the three most recent Inventory figures were $3.8 billion in Q4 2025, $3.8 billion in Q4 2024, and -$133.4 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 14.53 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 14.58 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 5.05 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 6.57 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | 3.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.84 Bn |
| Dec 31, 2024 | 3.80 Bn |
| Dec 31, 2023 | -133.42 Mn |
| Dec 31, 2022 | -86.72 Mn |
| Dec 31, 2021 | -181.58 Mn |
| Dec 31, 2020 | -146.19 Mn |
| Sep 30, 2020 | 2.32 Bn |
| Mar 31, 2020 | 2.72 Bn |
| Dec 31, 2019 | 2.59 Bn |
| Sep 30, 2019 | 2.59 Bn |
| Mar 31, 2019 | 2.40 Bn |
| Dec 31, 2018 | 2.22 Bn |
| Sep 30, 2018 | 2.17 Bn |
| Jun 30, 2018 | 2.16 Bn |
| Mar 31, 2018 | 2.06 Bn |
| Dec 31, 2017 | 1.92 Bn |
| Jun 30, 2017 | 1.75 Bn |
| Dec 31, 2016 | 1.77 Bn |
| Sep 30, 2016 | 1.72 Bn |
| Jun 30, 2016 | 1.73 Bn |